• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Dr. Paul Janssen Award for Biomedical Research issues 2015 call for nominations

Dr. Paul Janssen Award for Biomedical Research issues 2015 call for nominations

January 22, 2015
CenterWatch Staff

The Dr. Paul Janssen Award for Biomedical Research has opened its 2015 call for nominations. This prestigious award recognizes individuals whose scientific research has made, or has the potential to make, significant contributions toward the improvement of human health.

Nominations will be accepted until March 15 at www.pauljanssenaward.com for consideration by an independent selection committee of world-renowned scientists. Beginning in 2015, the cash prize awarded to the scientist or group of scientists receiving the award will be increased to $200,000. This increase in the monetary award reflects the growing importance of basic biomedical research, and continued recognition by Johnson & Johnson of excellence in the field.

The Dr. Paul Janssen Award for Biomedical Research honors Dr. Paul Janssen (1926-2003), who is widely recognized as one of the most productive scientists of the 20th century. Known throughout the scientific community as Dr. Paul, Janssen was responsible for breakthrough treatments in disease areas including pain management, psychiatry, infectious disease and gastroenterology, and founded Janssen Pharmaceutical, a Johnson & Johnson Company.

"Innovative science and technology have the power to transform the world," said Paul Stoffels, M.D., chief scientific officer and worldwide chairman, Pharmaceuticals, Johnson & Johnson. "Through the Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson honors the inspirational legacy of Dr. Paul and applauds today's researchers whose discoveries have the potential to transform the future of human health."

In 2014, the award was presented to Drs. Emmanuelle Charpentier and Jennifer Doudna, whose collaboration led to the discovery of a new method for precisely manipulating genetic information in ways that should produce new insights in health and disease, and may lead to the discovery of new targets for drug development. Charpentier and Doudna went on to win the 2015 Breakthrough Prize in Life Sciences. Other laureates of the 2015 Breakthrough Prize in Life Sciences included Drs. Victor Ambros and Gary Ruvkun, winners of the 2012 Dr. Paul Janssen Award.

Previous Award winners include David Julius, Ph.D., University of California San Francisco; Victor Ambros, Ph.D., University of Massachusetts Medical School; Gary Ruvkun, Ph.D., Massachusetts General Hospital and Harvard Medical School; Napoleone Ferrara, M.D., Genentech Fellow; Anthony S. Fauci, M.D., director, National Institute of Allergy and Infectious Diseases (NIAID); Erik De Clercq, M.D., Ph.D., chairman, Department of Microbiology and Immunology, Medical School at the Catholic University of Leuven; Axel Ullrich, Ph.D., director, Department of Molecular Biology, Max Planck Institute of Biochemistry in Germany; Professor Marc Feldmann, FMedSci, FAA, FRS, and Emeritus Professor Sir Ravinder Maini, FRCP, FMedSci, FRS, of the Kennedy Institute of Rheumatology, Imperial College London; and Craig Mello, Ph.D., Nobel Laureate, of the Howard Hughes Medical Institute and University of Massachusetts Medical School.

The 2015 Dr. Paul Janssen Award winner will be announced in spring 2015.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing